Literature DB >> 27844092

Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm.

Adejoke Yetunde Onaolapo1, Ajibola Nurudeen Adebayo2, Olakunle James Onaolapo3.   

Abstract

The immediate and short-term behavioural and physiological implications of exposure to stressful scenarios in the adolescent period are largely unknown; however, increases in occurrence of stress-related physiological and psychological disorders during puberty highlight the need to study substances that may modulate stress reactivity during a crucial stage of maturation. Seven groups of mice (12-15 g each) were administered distilled water (DW) (non-stressed and stressed controls), sertraline (10 mg/kg), diazepam (2 mg/kg) or one of three doses of melatonin (5, 10 and 15 mg/kg). Mice were exposed to 30 min of chronic mild stress (25 min of cage shaking, cage tilting, handling and 5 min of forced swimming in tepid warm water at 25 °C, in a random order) after administration of DW or drugs, daily for 21 days. Behavioural assessments were conducted on day 1 and day 21 (after which mice were sacrificed, blood taken for estimation of corticosterone levels and brain homogenates used for estimation of antioxidant activities). Administration of melatonin resulted in an increase in horizontal locomotion and self-grooming, while rearing showed a time-dependent increase, compared to non-stress and stress controls. Working memory improved with increasing doses of melatonin (compared to controls and diazepam); in comparison to setraline however, working memory decreased. A dose-related anxiolytic effect is seen when melatonin is compared to non-stressed and stressed controls. Melatonin administration reduced the systemic/oxidant response to repeated stress. Administration of melatonin in repeatedly stressed adolescent mice was associated with improved central excitation, enhancement of working memory, anxiolysis and reduced systemic response to stress.

Entities:  

Keywords:  Anxiety; Chronic stress; Memory; Neurohormone; Novelty-induced behaviours

Mesh:

Substances:

Year:  2016        PMID: 27844092     DOI: 10.1007/s00210-016-1314-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  75 in total

1.  Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors.

Authors:  Q Wan; H Y Man; F Liu; J Braunton; H B Niznik; S F Pang; G M Brown; Y T Wang
Journal:  Nat Neurosci       Date:  1999-05       Impact factor: 24.884

2.  Stress enhancement of fear learning in mice is dependent upon stressor type: Effects of sex and ovarian hormones.

Authors:  Matthew J Sanders; Sheryl Stevens; Henry Boeh
Journal:  Neurobiol Learn Mem       Date:  2010-06-19       Impact factor: 2.877

3.  A cognitive deficit induced in rats by chronic intermittent cold stress is reversed by chronic antidepressant treatment.

Authors:  M Danet; S Lapiz-Bluhm; David A Morilak
Journal:  Int J Neuropsychopharmacol       Date:  2010-02-11       Impact factor: 5.176

4.  The effects of chronic mild stress on male Sprague-Dawley and Long Evans rats: I. Biochemical and physiological analyses.

Authors:  C Bielajew; A T M Konkle; Z Merali
Journal:  Behav Brain Res       Date:  2002-11-15       Impact factor: 3.332

Review 5.  The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury.

Authors:  C Szabó
Journal:  Shock       Date:  1996-08       Impact factor: 3.454

6.  mt1 Melatonin receptor in the primate adrenal gland: inhibition of adrenocorticotropin-stimulated cortisol production by melatonin.

Authors:  Claudia Torres-Farfan; Hans G Richter; Pedro Rojas-García; Marcela Vergara; María L Forcelledo; Luis E Valladares; Fernando Torrealba; Guillermo J Valenzuela; María Serón-Ferré
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

7.  Effects of chronic social stress in adolescence on anxiety and neuroendocrine response to mild stress in male and female rats.

Authors:  C M McCormick; C Smith; I Z Mathews
Journal:  Behav Brain Res       Date:  2007-09-14       Impact factor: 3.332

8.  Protective effects of melatonin on renal failure in pinealectomized rats.

Authors:  Hakan Parlakpinar; Ahmet Acet; Mehmet Gul; Eyup Altinoz; Mukaddes Esrefoglu; Cemil Colak
Journal:  Int J Urol       Date:  2007-08       Impact factor: 3.369

Review 9.  Melatonin receptors in humans: biological role and clinical relevance.

Authors:  C Ekmekcioglu
Journal:  Biomed Pharmacother       Date:  2006-02-20       Impact factor: 6.529

10.  Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam.

Authors:  Florence Loiseau; Claudine Le Bihan; Michel Hamon; Marie-Hélène Thiébot
Journal:  Eur Neuropsychopharmacol       Date:  2006-01-11       Impact factor: 4.600

View more
  6 in total

1.  Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy.

Authors:  Olakunle James Onaolapo; Olayemi Quyyom Ademakinwa; Temitayo Opeyemi Olalekan; Adejoke Yetunde Onaolapo
Journal:  Psychopharmacology (Berl)       Date:  2017-06-14       Impact factor: 4.530

2.  Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.

Authors:  O J Onaolapo; T B Paul; A Y Onaolapo
Journal:  Metab Brain Dis       Date:  2017-05-15       Impact factor: 3.584

3.  Effects of a physical and energetic challenge on male California mice (Peromyscus californicus): modulation by reproductive condition.

Authors:  Meng Zhao; Theodore Garland; Mark A Chappell; Jacob R Andrew; Breanna N Harris; Wendy Saltzman
Journal:  J Exp Biol       Date:  2018-01-11       Impact factor: 3.312

Review 4.  Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin's roles in prophylaxis and management.

Authors:  Adejoke Y Onaolapo; Olakunle J Onaolapo
Journal:  World J Diabetes       Date:  2018-07-15

Review 5.  Melatonin and Comorbidities in Children with Autism Spectrum Disorder.

Authors:  Katia Gagnon; Roger Godbout
Journal:  Curr Dev Disord Rep       Date:  2018-08-09

Review 6.  Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.

Authors:  Olakunle J. Onaolapo; Adejoke Y. Onaolapo; Olugbenga A. Olowe; Mojisola O. Udoh; David O. Udoh; Thomas I. Nathaniel
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.